Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03010527
Status:
COMPLETED
Last Update Posted:
2022-10-18
First Post:
2017-01-03
Brief Title:
A Study to Evaluate the Long-term Safety Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-03
First Submit QC Date:
January 3 2017
Study First Post Date:
2017-01-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-10-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-09-24
Disp First Submit QC Date:
September 24 2019
Disp First Post Date:
2019-10-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-09-27
Last Update Post Date:
2022-10-18
Last Update Post Date Type:
ACTUAL